title: Prolonged survival of a patient with inoperable, locally advanced adenocarcinoma of pancreas after autologous immune enhancement therapy with chemotherapy.
authors.forename: S
authors.initials: S
authors.lastname: Baskar
authors.forename: V D
authors.initials: VD
authors.lastname: Dedeepiya
authors.forename: H
authors.initials: H
authors.lastname: Terunuma
authors.forename: S R
authors.initials: SR
authors.lastname: Manjunath
authors.forename: R
authors.initials: R
authors.lastname: Senthilkumar
authors.forename: G
authors.initials: G
authors.lastname: Sivaraman
authors.forename: A
authors.initials: A
authors.lastname: Pandian
authors.affiliation: The Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India; Department of Clinical Research, Yamanashi University-School of Medicine, Chuo, Japan, .
authors.forename: S J K
authors.initials: SJ
authors.lastname: Abraham
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D000328:Adult; D004358:Drug Therapy / Q000379:methods*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D016019:Survival Analysis